MediWound (MDWD) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $11.85, -2.95% vs the prior close of $12.21.
- Volume 33.44K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MDWD dips 2.9% to $11.85, a 52-week low. Closed at $11.85, -2.95% vs the prior close of $12.21. Day range $11.84–$12.24, opened at $12.24.
MDWD daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — MDWD dips 2.9% to $11.85, a 52-week low
- Closed at $11.85, -2.95% vs the prior close of $12.21. Day range $11.84–$12.24, opened at $12.24.
- Volume was 33.44K shares, 0.4x its 50-day average of 89.74K — lighter than usual.
- Price is -10.7% vs its 50-day average ($13.27) and -23.6% vs its 200-day average ($15.51).
- 52-week range $11.84–$20.03; today's close sits at 0% of that range, 40.8% below the 52-week high.
Oct 15, 2026 — MDWD rises 2.5% to $12.21
- Closed at $12.21, +2.52% vs the prior close of $11.91. Day range $11.87–$12.23, opened at $11.99.
- Volume was 93.10K shares, 1.0x its 50-day average of 89.19K.
- Price is -8.3% vs its 50-day average ($13.31) and -21.5% vs its 200-day average ($15.55).
- 52-week range $11.87–$20.03; today's close sits at 4% of that range, 39.0% below the 52-week high.
Oct 14, 2026 — MDWD dips 2.5% to $11.91, a 52-week low
- Closed at $11.91, -2.54% vs the prior close of $12.22. Day range $11.90–$12.34, opened at $12.19.
- Volume was 91.80K shares, 1.0x its 50-day average of 88.70K.
- Price is -10.8% vs its 50-day average ($13.35) and -23.6% vs its 200-day average ($15.58).
- 52-week range $11.90–$20.03; today's close sits at 0% of that range, 40.5% below the 52-week high.
Oct 13, 2026 — MDWD dips 2.7% to $12.22, a 52-week low
- Closed at $12.22, -2.71% vs the prior close of $12.56. Day range $12.19–$12.62, opened at $12.55.
- Volume was 80.40K shares, 0.9x its 50-day average of 88.30K.
- Price is -8.8% vs its 50-day average ($13.40) and -21.7% vs its 200-day average ($15.61).
- 52-week range $12.19–$20.03; today's close sits at 0% of that range, 39.0% below the 52-week high.
Oct 12, 2026 — MDWD ends flat (+0.2%) to $12.56
- Closed at $12.56, +0.16% vs the prior close of $12.54. Day range $12.35–$12.69, opened at $12.50.
- Volume was 65.60K shares, 0.7x its 50-day average of 88.50K.
- Price is -6.6% vs its 50-day average ($13.44) and -19.7% vs its 200-day average ($15.65).
- 52-week range $12.35–$20.03; today's close sits at 3% of that range, 37.3% below the 52-week high.
Oct 9, 2026 — MDWD rises 1.0% to $12.54
- Closed at $12.54, +0.97% vs the prior close of $12.42. Day range $12.42–$13.15, opened at $12.42.
- Volume was 92.60K shares, 1.1x its 50-day average of 88.01K.
- Price is -6.9% vs its 50-day average ($13.47) and -20.0% vs its 200-day average ($15.68).
- 52-week range $12.42–$20.03; today's close sits at 2% of that range, 37.4% below the 52-week high.
Oct 8, 2026 — MDWD slides 3.3% to $12.42, a 52-week low, 8 down days in a row
- Closed at $12.42, -3.35% vs the prior close of $12.85. Day range $12.42–$13.11, opened at $12.80.
- Volume was 104.40K shares, 1.2x its 50-day average of 87.44K.
- Price is -8.0% vs its 50-day average ($13.50) and -20.9% vs its 200-day average ($15.71).
- 52-week range $12.42–$20.03; today's close sits at 0% of that range, 38.0% below the 52-week high.
- That makes 8 straight losses.
Oct 7, 2026 — MDWD dips 2.3% to $12.85, a 1-month low, 7 down days in a row
- Closed at $12.85, -2.28% vs the prior close of $13.15. Day range $12.81–$13.23, opened at $13.13.
- Volume was 72.50K shares, 0.8x its 50-day average of 86.92K.
- Price is -5.1% vs its 50-day average ($13.54) and -18.4% vs its 200-day average ($15.74).
- 52-week range $12.52–$20.03; today's close sits at 4% of that range, 35.8% below the 52-week high.
- That makes 7 straight losses.
Oct 6, 2026 — MDWD dips 2.7% to $13.15, 6 down days in a row
- Closed at $13.15, -2.66% vs the prior close of $13.51. Day range $13.10–$13.53, opened at $13.51.
- Volume was 58.80K shares, 0.7x its 50-day average of 86.78K.
- Price is -3.2% vs its 50-day average ($13.58) and -16.6% vs its 200-day average ($15.77).
- 52-week range $12.52–$20.03; today's close sits at 8% of that range, 34.3% below the 52-week high.
- That makes 6 straight losses.
Oct 5, 2026 — MDWD ends flat (-0.1%) to $13.51, 5 down days in a row
- Closed at $13.51, -0.07% vs the prior close of $13.52. Day range $13.30–$13.63, opened at $13.48.
- Volume was 49.90K shares, 0.6x its 50-day average of 86.69K — lighter than usual.
- Price is -0.7% vs its 50-day average ($13.60) and -14.5% vs its 200-day average ($15.80).
- 52-week range $12.52–$20.03; today's close sits at 13% of that range, 32.6% below the 52-week high.
- That makes 5 straight losses.
Oct 2, 2026 — MDWD dips 0.6% to $13.52, 4 down days in a row
- Closed at $13.52, -0.59% vs the prior close of $13.60. Day range $13.43–$13.78, opened at $13.68.
- Volume was 48.00K shares, 0.6x its 50-day average of 87.20K — lighter than usual.
- Price is -0.7% vs its 50-day average ($13.62) and -14.6% vs its 200-day average ($15.82).
- 52-week range $12.52–$20.03; today's close sits at 13% of that range, 32.5% below the 52-week high.
- That makes 4 straight losses.
MDWD latest news & SEC filings
Every SEC filing by or about MDWD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Rubinstein Samuel bought 525 shares at $12.62 (≈$6.63K) on Sep 1, 2026
- Rubinstein Samuel sold 525 shares at $12.72 (≈$6.68K) on Sep 1, 2026
- Rubinstein Samuel bought 525 shares at $12.62 (≈$6.63K) on Sep 1, 2026
- Rubinstein Samuel sold 525 shares at $12.72 (≈$6.68K) on Sep 1, 2026
- Rubinstein Samuel bought 525 shares at $12.62 (≈$6.63K) on Sep 1, 2026
- Rubinstein Samuel sold 525 shares at $12.72 (≈$6.68K) on Sep 1, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hess Shmuel sold 1,979 shares at $13.13 (≈$25.98K) on Aug 27, 2026
- Hess Shmuel sold 1,979 shares at $12.72 (≈$25.17K) on Aug 27, 2026
- Hess Shmuel sold 1,979 shares at $13.13 (≈$25.98K) on Aug 27, 2026
- Hess Shmuel sold 1,979 shares at $12.72 (≈$25.17K) on Aug 27, 2026
- Hess Shmuel sold 1,979 shares at $13.13 (≈$25.98K) on Aug 27, 2026
- Hess Shmuel sold 1,979 shares at $12.72 (≈$25.17K) on Aug 27, 2026
- …plus 6 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 28, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 28, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade MDWD
- How much it moves: over the last 20 sessions the average daily move was 1.64% (largest 4.8%).
- Liquidity: about 70.14K shares (≈$831.13K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $11.85 vs a range of $11.84–$20.03 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 9 open-market buys, 16 sales; latest: Samuel Rubinstein bought 525 shares on Sep 1, 2026.
- Latest filings: 6-K Aug 13, 2026; 6-K May 27, 2026; 6-K May 6, 2026.
- Listing: Nasdaq · industry: Medicinal Chemicals & Botanical Products.
MDWD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 12.24 | 12.24 | 11.84 | 11.85 | 33.44K |
| Oct 15, 2026 | 11.99 | 12.23 | 11.87 | 12.21 | 93.10K |
| Oct 14, 2026 | 12.19 | 12.34 | 11.90 | 11.91 | 91.80K |
| Oct 13, 2026 | 12.55 | 12.62 | 12.19 | 12.22 | 80.40K |
| Oct 12, 2026 | 12.50 | 12.69 | 12.35 | 12.56 | 65.60K |
| Oct 9, 2026 | 12.42 | 13.15 | 12.42 | 12.54 | 92.60K |
| Oct 8, 2026 | 12.80 | 13.11 | 12.42 | 12.42 | 104.40K |
| Oct 7, 2026 | 13.13 | 13.23 | 12.81 | 12.85 | 72.50K |
| Oct 6, 2026 | 13.51 | 13.53 | 13.10 | 13.15 | 58.80K |
| Oct 5, 2026 | 13.48 | 13.63 | 13.30 | 13.51 | 49.90K |
| Oct 2, 2026 | 13.68 | 13.78 | 13.43 | 13.52 | 48.00K |
| Oct 1, 2026 | 13.66 | 13.77 | 13.47 | 13.60 | 81.50K |
| Sep 30, 2026 | 13.80 | 13.98 | 13.59 | 13.77 | 83.90K |
| Sep 29, 2026 | 14.04 | 14.04 | 13.74 | 13.80 | 30.20K |
| Sep 28, 2026 | 13.68 | 14.00 | 13.68 | 13.93 | 56.60K |
| Sep 25, 2026 | 13.86 | 14.03 | 13.70 | 13.84 | 72.60K |
| Sep 24, 2026 | 13.77 | 13.97 | 13.50 | 13.83 | 61.10K |
| Sep 23, 2026 | 13.80 | 13.80 | 13.33 | 13.65 | 73.10K |
| Sep 22, 2026 | 13.38 | 13.99 | 13.38 | 13.95 | 80.70K |
| Sep 21, 2026 | 13.49 | 13.49 | 13.00 | 13.31 | 72.50K |
About MediWound
MediWound (MDWD) is listed on the Nasdaq and classified by the SEC under “Medicinal Chemicals & Botanical Products”. Its business address is in YAVNE, Israel. State of incorporation: Israel. Fiscal year ends December 31. SEC CIK 1593984.
MDWD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Vickie Rae Driver | Director | Mar 25, 2026 |
| David Morton Fox | Director | Jun 2, 2026 |
| Samuel Rubinstein | Director | Sep 2, 2026 |
| Nachum Shamir | Director | Jun 4, 2026 |
| Stephen T Wills | Director | Mar 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Yaakov Aya Ben | VP Clinical & Reg. Affairs | Mar 18, 2026 |
| Ofer Gonen | Chief Executive Officer | Mar 18, 2026 |
| Shmuel Hess | COO & Chief Commercial Officer | Aug 28, 2026 |
| Ety Klinger | Chief Medical Officer | Mar 18, 2026 |
| Kalfon Hana Luxenburg | Chief Financial Officer | Mar 18, 2026 |
| Yaron Meyer | EVP, GC & Corp. Secretary | Mar 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 1, 2026 | Samuel Rubinstein | Buy | 525 | $12.62 |
| Sep 1, 2026 | Samuel Rubinstein | Sale | 525 | $12.72 |
| Sep 1, 2026 | Samuel Rubinstein | Buy | 525 | $12.62 |
| Sep 1, 2026 | Samuel Rubinstein | Sale | 525 | $12.72 |
| Sep 1, 2026 | Samuel Rubinstein | Buy | 525 | $12.62 |
| Sep 1, 2026 | Samuel Rubinstein | Sale | 525 | $12.72 |
| Sep 1, 2026 | Samuel Rubinstein | Buy | 525 | $12.62 |
| Sep 1, 2026 | Samuel Rubinstein | Sale | 525 | $12.72 |
| Aug 27, 2026 | Shmuel Hess | Sale | 1,979 | $13.13 |
| Aug 27, 2026 | Shmuel Hess | Sale | 1,979 | $12.72 |
| Aug 27, 2026 | Shmuel Hess | Sale | 1,979 | $13.13 |
| Aug 27, 2026 | Shmuel Hess | Sale | 1,979 | $12.72 |
| Aug 27, 2026 | Shmuel Hess | Sale | 1,979 | $13.13 |
| Aug 27, 2026 | Shmuel Hess | Sale | 1,979 | $12.72 |
| Aug 27, 2026 | Shmuel Hess | Sale | 1,979 | $13.13 |
MDWD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
MDWD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Medicinal Chemicals & Botanical Products
Definium Therapeutics (DFTX)Trulieve Cannabis (TRLV)Tilray Brands (TLRY)IM Cannabis (IMCC)Glass House Brands (GLAS)Aurora Cannabis (ACB)Cronos (CRON)Usana Health Sciences (USNA)Regencell Bioscience (RGC)Canopy Growth (CGC)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MDWD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.